Lung Cancer Clinical Trials

Lung Cancer Clinical Trials

  • 05.0523 - Preoperative Metabolomic Analysis of Primary Lung Cancer: a Translational Clinical Trial of the Brown Cancer Center  learn more
  • 07.0065 - Allogeneic Cellular Vaccine 1650-G for Non-Small Cell Lung Cancer (NSCLC)  learn more
  • 08.0040 - Berry Interventional Trial (BIT) in Resected Non-Small Cell Lung Cancer  learn more
  • 08.0388 - Protocol for the Cancer Database and Specimen Repository (CDSR) at the James Graham Brown Cancer Center (Previous Lung Repository )  learn more
  • 08.0405 - Phase 3 Study of Pemetrexed, Cisplatin, and Radiotherapy Followed by Consolidation Pemetrexed versus Etoposide, Cisplatin, and Radiotherapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Patients with Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer Other than Predominantly Squamous Cell Histology  learn more
  • 09.0065 - Lung Cancer Survival: A Multifactorial Approach  learn more
  • 07.0210  - A Phase II Trial Using Intravenous Iron in Advanced Lung Cancer Patients with Chemotherapy Induces Anemia Treated with 40,000 Units of Epoetin Alfa Every Three Weeks  learn more
  • 09.0075  - A Phase III Randomized Trial of Adjuvant Chemotherapy With or Without Bevacizumab for Patients with Completely Resected Stage IB (≥ 4cm) – IIIA Non-Small Cell Lung Cancer (NSCLC)  learn more
  • 09.0048 - A Phase III, Randomized, Double-blind, Placebo-controlled Multi-center Study of ASA404 in Combination with Docetaxel in Second-line Treatment of Patients with Advanced or Metastatic (Stage IIIb-IV) Non-Small Cell Lung Cancer (NSCLC).  learn more
  • 08.0468 - A Randomized Phase III Comparison of Standard Dose (60 Gy) Versus High Dose (74 Gy) Conformal Radiotherapy with Concurrent and Consolidation Carboplatin/Paclitaxel in Patients with Stage IIIA/IIIB Non-Small Cell Lung Cancer.  learn more
  • BCC-LUN-09-001 Neutro - In Vitro Cytotoxicity of Neutrophils from Patients with Lung Cancer and Patients without Malignancy  learn more